THE ROLE OF A SCIENCE LABORATORY TECHNOLOGIST IN THE RACE FOR A VACCINE FOR COVID 19.

CHIEF IRIKEFE AKPORIDO (B.sc. SLT. BIOLOGICAL TECHNOLOGY -DELSU., M.sc PUBLIC HEALTH -U.S.A, F.NISLT, NISP, NEBOSH, APHA AND SOPHE MEMBERSHIP-#31682).

Vaccine developers are fast-tracking new constructs of various kinds—traditional vaccines, RNA vaccines, DNA vaccines, and others, in hopes of catching up with COVID-19, the deadly respiratory disease that already circles the globe. Developers are also interested in trying to trip up COVID-19 by repurposing vaccines already developed to counter pathogens like SARS-CoV-2. The worldwide scientific mobilization to produce a SARS-CoV-2 vaccine has become a race against time and an escalation in the heated rivalry among competing companies. All are scrambling toward the same goal: producing a vaccine against a viral menace that emerged in central China late last year and is now circling the globe.

As at today 12th May 2020, more than 2 million people around the world had become infected with covid 19, and unfortunately over 4 thousand of these infected people are from my home country NIGERIA., also global deaths had already breached the 100,000 mark, and over a 100 of them are also from my country NIGERIA according to report from the Nigeria Center For Disease Control (NCDC), with no end to the pandemic’s exponential growth in sight. It will be months, before laboratory technologist and public health officials say or known whether either of the vaccines entering clinical trials will be widely used to effectively immunize populations against SARS-CoV-2. Multiple other candidate vaccines are being studied by research teams globally, and several are set to be launched into clinical testing within the next few weeks to months.

Finding a safe and effective vaccine to prevent an increase in the spread of SARS-CoV-2 infection is an urgent laboratory technologist and a public health officer's priority. it is impossible to give a precise date when a vaccine will be ready for what will amount to tens of millions of immunizations. The types of SARS-CoV-2 vaccines under development worldwide are mostly genomic, DNA or RNA. However, the novel coronavirus differs in subtle, yet significant ways compared with previous members of the coronavirus family, SARS-CoV-1 and Middle East respiratory syndrome–related coronavirus (MERS-CoV). These viruses seem to primarily infect the lower respiratory tract, and lightly makes it difficult to spread between humans. But the new SARS-CoV-2, however, seems to replicate well in the upper respiratory tract, grows there quickly to high viral loads, and is able to spread between humans, who transmit it simply by droplets produced during breathing and coughing.

Therefore in conclusion, if all proceeds as planned, the federal government of Nigeria, through the institute of science laboratory technology, under the federal ministry of science and technology, should immediately make available an estimated sum of $9million or more to support science laboratory technology preclinical and clinical research work. This fund will be used to setup a vaccine development plant, which will accelerate vaccine production and testing in Nigeria.

Feel free to forward any question you might have to the email below or call the number to ask your question.
Thank you.

M.D IRIKEFE CORPORATE SERVICES

YOU CAN LIKE OUR FACEBOOK PAGE : IRIKEFE CORPORATE SERVICES 

Irikefeman@yahoo.com

LECTURE ON COVID-19; FROM IRIKEFE BIOLOGICAL RESEARCH LABORATORY. (CLINICAL LABORATORY SERVICE)

LECTURER : CHIEF IRIKEFE AKPORIDO (B. sc. SLT BIOLOGICAL TECHNOLOGY, M. sc PUBLIC HEALTH, F.NISLT.)

TOPIC TITLED : SAFETY IN THE LABORATORY DURING A PANDEMIC.

The COVID-19 pandemic has put laboratories on edge, even if they’re not testing for the novel coronavirus, COVID-19 is highly infectious; symptoms are mild or nonexistent for some, but fatal for others. Lab safety is always a top priority, but rules can sometimes fall by the wayside. Equipment, for example, might not get cleaned as often as the protocol demands, and employees may not always strictly adhere to safe work practices. Now is the time to protect your laboratory, your colleagues, and yourself.

PRACTICAL STEPS TO MITIGATE YOUR LABORATORY RISK DURING A PANDEMIC

Even if your laboratory team is working with a skeleton crew and only performing mission-critical tasks, like keeping precious cultures alive, during the pandemic, it should still strictly abide by standard lab safety protocols. Risk prevention, Lab Manager says, requires both individual precautions and lab-specific measures.

INDIVIDUAL PRECAUTIONS DURING PANDEMIC

Whether they’re coming to the laboratory or not, everyone should carefully follow the precautions prescribed by the Centers for Disease Control and Prevention (CDC) and NIgerian Institute Of Science Laboratory Technology (NISLT) .

(1.) Wash your hands frequently, especially after contacting commonly touched surfaces.   Use soap and water, and wash for at least 20 seconds. If soap and water aren’t available, use a hand sanitizer with at least 60 percent alcohol.

(2.) Don’t touch your face if you haven’t washed your hands.
Stay home if you feel sick and encourage others to do the same. If you’ve been exposed to the virus and you develop its common symptoms i.e dry cough, fever and difficulty breathing — seek immediate medical attention. Stay home to further minimize potential exposure. Avoid any contact with sick people.

LABORATORY SPECIFIC PRECAUTIONS DURING A PANDEMIC

To ensure the laboratory is safe for everyone, staff should exercise extra precautions to minimize the risk of person-to-person infection and surface contamination.

(1.) Follow the guidelines established by the Occupational Safety and Health Administration and the Nigerian Institute Of Science Laboratory Technology (NISLT), about readying workplaces for the coronavirus.

(2.) Limit close contact, Be aware of where others are in the lab and keep as much distance as possible. Limit movements throughout the laboratory to essential trips. Remote working policies and stagger shifts when possible to minimize the number people in the lab at one time.

(3.) Promote proper hand hygiene. Provide hand-washing stations throughout the lab and ensure that hand sanitizer is well stocked and readily available.

(4.) Clean and disinfect frequently touched surfaces, such as equipment and cabinet handles, with products that meet the Environmental Protection Agency‘s criteria for use against the SARS-CoV-2 virus. Wear personal protective equipment(PPE) while cleaning, wipe down resuable PPE afterward.

 (5). If someone working in the laboratory contracts COVID-19, follow the protocols established by the CDC and NCDC., Close off and decontaminate any areas used by the sick person with an EPA-recommended disinfectant. Engage a professional decontamination service, if necessary.

Ensure that every member of the laboratory knows and understands the latest protocols and policies. Use a checklist, such as this one from the Association of Public Health Laboratories and Nigerian Institute Of Science Laboratory (NISLT), to assess potential safety hazards. If ever there were a time to reassess your laboratory’s safety policies, it’s now. If your laboratory’s protocols need to be updated, whether to deal with the novel coronavirus or just because it’s time, update them.

Be diligent and thorough. Inaction could have grave consequences for you or someone around you. As a laboratory professional, you’re on the frontlines of the fight to slow the spread of COVID-19.

Feel free to forward any question you might have to the email below to ask your question.

Thank you

irikefeman@yahoo.com